Stock markets struggled with what to make of the latest from the Federal Reserve, then finally plunged to end the trading ...

Wall Street set records on Thursday, even as a sell-off for Oracle and worries about a potential bubble in ...

JPMorgan’s reinvestment strategy and tech focus boost long-term value, with 2025 growth targets and a $300–$320 fair value.

Viomi (VIOT) stock is a top buy for 2025 with strong US entry, advanced AI products, undervalued shares, and impressive ...

Strategy MSTR, the bitcoin-holding company, remains part of the Nasdaq 100 index after the annual reconstitution announced Friday evening. MSCI is considering whether to exclude companies whose ...

The NFL expressed its concern about the rise of prediction markets to a congressional committee Thursday, stating that the ...

Follow live updates on the Dow, S&P 500 and Nasdaq and the top business, finance and economics stories.

The managing partner of $6.3 billion Douglass Winthrop Advisors thinks higher inflation and tariff uncertainty could trip up ...

US stocks are trading at valuations that leave little room for error, and some of the savviest investors are quietly voting ...

Novo Nordisk NVO has stumbled through 2025, with its shares down 41.5% year to date despite finally resolving U.S. supply constraints for its semaglutide-based GLP-1 blockbusters — Ozempic for type II ...

Discover why SPDR S&P 500 ETF (SPY) is rated Buy for 2026 with a projected 6.8% return amid market volatility.